Skip to main content
    M

    Mereo BioPharma Group PLC ADR (MREO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.27
    -0.03 (-10.00%)

    Market Cap: $48.71M

    Last updated: Nov 17, 2026 at 4:36 PM ET

    Mereo BioPharma Group PLC ADR (MREO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Mereo BioPharma Group PLC ADR (MREO) has a market cap of $48.71M. It has 160.91M shares outstanding.

    Total Valuation

    Market Cap$48.71M
    Latest price (Nov 17, 2026)$0.27

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.12% in the quarter ended Sep 30, 2026 and grew 128.54% a year over 2 years.

    Shares Outstanding160.91M
    Shares Change (YoY)+0.57%
    Shares Change (QoQ)+0.12%
    Share Count Growth (2Y CAGR)+128.54%

    Valuation Ratios

    Sales and book value multiples are 55.2x and 1.9x. Its year-end P/S ranged from 0.3x to 486.5x from 2021 to 2025.

    P/S Ratio55.2x
    P/B Ratio1.9x

    Valuation history and multiples

    Price Statistics

    The stock is down 84.58% over 52 weeks and trades 12.90% below its 50-day average.

    Beta (1Y)1.70
    52-Week Change-84.58%
    1-Month Change-9.14%
    3-Month Change-11.88%
    6-Month Change+15.34%
    5-Year Change-87.13%
    Total Return (1Y)-84.58%
    Total Return (3Y CAGR)-49.08%
    Total Return (5Y CAGR)-33.19%
    Max Drawdown (1Y)-89.73%
    Max Drawdown (3Y)-95.13%
    Sharpe Ratio (1Y)-0.83
    Correlation with SPY (1Y)0.10
    50-Day Average$0.31
    200-Day Average$0.32
    52-Week Range$0.20 to $2.37
    RSI (14 Days)39.5
    Average Volume (20 Days)682.79K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.22x current liabilities, and total debt is 0.02x shareholder equity.

    Current Ratio5.22x
    Quick Ratio5.22x
    Debt / Equity0.02x
    Interest Coverage-419.15x

    Returns and Efficiency

    Return on invested capital is -116.15% over the last 12 months, against a 5-year average of -45.60%.

    Return on Assets (ROA)-91.02%
    Return on Invested Capital (ROIC)-116.15%
    ROIC (5Y Average)-45.60%
    Receivables Turnover0.63x

    Scores

    MREO has an Altman Z-Score of -22.37, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-22.37
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MREO

    What is MREO's market cap?

    Mereo BioPharma Group PLC ADR has a market cap of $48.71M.

    How many shares of MREO are outstanding?

    Mereo BioPharma Group PLC ADR has 160.91M shares outstanding. The count is up 0.57% from a year earlier.

    Does MREO pay a dividend?

    No. Mereo BioPharma Group PLC ADR does not pay a dividend.